Evidence map›Paper›PMID 40956082›Full record

ArticleJournal of virology2025

Positive correlation between structural disorder of the HIV-1 Gag N-terminal segment and progeny virus particle formation.

Takaaki Koma, Osamu Kotani, Keisuke Kamba, Kei Miyakawa, Taiki Morita, Hiromi Nakamura, Masaru Yokoyama, Naoya Doi, Tomoyuki Kondo, Takashi Nagata and 6 more

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Takaaki Koma *Department of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima, Tokushima, Japan.ORCID 0000-0001-9767-990X
Osamu Kotani *Pathogen Genomics Center, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.ORCID 0000-0003-1665-6824
Keisuke Kamba *Institute of Advanced Energy, Kyoto University, Uji, Kyoto, Japan.
Kei MiyakawaResearch Center for influenza and Respiratory Viruses, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Taiki MoritaInstitute of Advanced Energy, Kyoto University, Uji, Kyoto, Japan.
Hiromi NakamuraPathogen Genomics Center, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Masaru YokoyamaPathogen Genomics Center, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Naoya DoiDepartment of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima, Tokushima, Japan.
Tomoyuki KondoDepartment of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima, Tokushima, Japan.
Takashi NagataInstitute of Advanced Energy, Kyoto University, Uji, Kyoto, Japan.
Akihide RyoDepartment of Virology III, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.
Akio AdachiDepartment of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima, Tokushima, Japan.ORCID 0000-0003-1674-332X
Akira OnoDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan, USA.ORCID 0000-0001-7841-851X
Masato KatahiraInstitute of Advanced Energy, Kyoto University, Uji, Kyoto, Japan.ORCID 0000-0003-0336-7660
Masako NomaguchiDepartment of Microbiology, Graduate School of Medicine, Tokushima University, Tokushima, Tokushima, Japan.ORCID 0000-0003-3708-4511
Hironori SatoPathogen Genomics Center, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan.ORCID 0000-0002-3746-4672

Funding

Mechanisms that determine subcellular sites of HIV-1 assemblyR37AI071727 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Akira Ono · 2017 to 2026
$6.2M
Mechanisms that determine subcellular sites of HIV-1 assemblyR01AI071727 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ONO, AKIRA · 2007 to 2016
$3.6M
Japan Agency for Medical Research and Development JP22ak0101097Japan Agency for Medical Research and Development JP24fk0410048, JP23fk0410048, JP22fk0410048Japan Society for the Promotion of Science 20K06524, 23K05664Japan Society for the Promotion of Science 22K07102Japan Society for the Promotion of Science 22K15558Japan Society for the Promotion of Science 23H02419, 23H04069, 24K21946NIAID NIH HHS R01 AI071727NIAID NIH HHS R37 AI071727NIH HHS R37 AI071727Takeda Science Foundation
6 · The paper itself

Abstract

A class of unstructured peptide segments termed disordered regions plays a crucial role in the regulation of protein structure and function. Although the N-terminal region of the matrix (MA) domain of the HIV-1 Gag precursor protein is composed of an unstructured peptide, the mechanisms underlying the regulation of the unstructured state relating to control of viral phenotypes remain unclarified. We examined, in association, the structural, evolutionary, and biological roles of the MA N-terminal region via mutagenesis. Molecular dynamics simulation of a full-length Gag dimer model suggested that an amino acid residue at position 9 in the MA N-terminal region (MA-9) participates in the Gag dimerization. Information entropy analysis indicated that the MA-9 residue is variable in nature, but the hydrophobic amino acid substitution is evolutionarily maladaptive. Disordered region prediction study suggested that single hydrophobic amino acid substitutions at MA-9 reduce the disordered state of the MA N-terminal region. Consistently, NMR analysis indicated that such substitution reduces motional dynamics of the MA N-terminal region and alters the conformation of the MA domain. A site-directed mutagenesis study showed that hydrophobic amino acid substitutions at the MA-9 residue impair, to different degrees, the elementary and overall processes of virus particle formation in the cells. Importantly, the level of the virus particle formation was positively correlated with the level of disorder of the MA N-terminal region. These results indicate that the maintenance of structural disorder and dynamics of the Gag N-terminal segment is regulated by the MA-9 residue and critical for maintaining the optimal production of HIV-1 particles.IMPORTANCEA class of unstructured peptide segments termed disordered regions plays crucial roles in the regulation of protein structure and function. Although HIV-1 Gag precursor protein has multiple disordered elements, molecular mechanisms underlying regulation of unstructured state and viral phenotypes largely remain elusive. In this study, by analyzing in association the structural, evolutionary, and virological roles of the disordered N-terminal region of the HIV-1 Gag protein, we show that an amino acid residue at position 9 of the Gag is able to modulate the N-terminal disordered state, and the level of disorder of the Gag N-terminal region is positively correlated with the level of virus particle formation. Our findings gain new insights into molecular mechanisms of regulation of Gag structure and highlight the importance of a previously unappreciated survival strategy of HIV-1-namely, preservation of the Gag N-terminal disorder.

Indexed as

gag Gene Products, Human Immunodeficiency VirusHIV-1Protein PrecursorsVirus AssemblyAmino Acid SubstitutionHEK293 CellsHeLa CellsHumansHydrophobic and Hydrophilic InteractionsMolecular Dynamics SimulationMutagenesis, Site-DirectedNuclear Magnetic Resonance, BiomolecularProtein DomainsProtein MultimerizationViriongag Gene Products, Human Immunodeficiency VirusProtein PrecursorsGagHIV-1structural disordervirus particle production

Identifiers

PMID40956082
PMCPMC12548442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.